Policy The FDA authorized ENDS list is a product-intelligence tool, not a marketing badge.
What changed in the information environment
As of June 1, 2026, FDA maintains a public authorized e-cigarette list and says the authorized ENDS products on that list are the only e-cigarettes that may currently be lawfully sold in the United States. That makes the list a practical reference point for retailers, distributors, and media teams tracking product status.
The list should not be treated as an endorsement or a claim that a product is safe. FDA explicitly separates marketing authorization from safety language. For VapeRisk readers, that distinction is the starting point.
How a retailer should use it
A retailer should check product name, manufacturer, device or pod variant, nicotine strength, flavor, and whether the exact SKU appears in an official source. Similar branding is not enough; the exact product matters.
The useful workflow is simple: match the shelf product to the public listing, store a screenshot or source link in the intake file, and re-check when supplier documents change.
VapeRisk takeaway
Regulatory status is now part of product intelligence. A strong review or buying guide cannot only discuss flavor and battery life; it should also explain whether the product category sits inside a clear compliance pathway or a gray market.